Skip to content

Clinical trials

Phase 1 Fallopian Tube Neoplasms trials in Canada

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Fallopian Tube Neoplasms Phase: Phase 1 Country / region: Canada Clear all

11 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20021
20112
20131
20151
20181
20222
20231

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed6
Active, not recruiting2
Terminated2
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
ImmunoVaccine Technologies, Inc. (IMV Inc.)2
University Health Network, Toronto2
AbbVie1
Alliance for Clinical Trials in Oncology1
British Columbia Cancer Agency1
Gynecologic Oncology Group1
National Cancer Institute (NCI)1
Seagen, a wholly owned subsidiary of Pfizer1
Shattuck Labs, Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Fallopian Tube Neoplasms11
Ovarian Neoplasms7
Carcinoma, Ovarian Epithelial5
Endometrial Neoplasms3
Neoplasms2
Peritoneal Neoplasms2
Recurrence2
Uterine Cervical Neoplasms2
Anus Neoplasms1
Brenner Tumor1

Trials

Showing 1 to 11 of 11. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.